US OptionsDetailed Quotes
AMED250117C90000
- 0.70
- 0.000.00%
15min DelayClose Dec 24 13:00 ET
0.70High0.65Low
0.65Open0.70Pre Close11 Volume4.56K Open Interest90.00Strike Price720.00Turnover30.98%IV6.52%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.70Extrinsic Value100Contract SizeAmericanOptions Type0.2662Delta0.0487Gamma81.10Leverage Ratio-0.0492Theta0.0141Rho21.59Eff Leverage0.0714Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Kofi : Do u see it going above 100 ?